BCM
MBIO icon

Bridgeway Capital Management’s Mustang Bio MBIO Stock Holding History

Bridgeway Capital Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-284
Closed -$84K – 1409
2022
Q4 		$84K Sell
284
-66
-19% -$22.5K ﹤0.01% 1242
2022
Q3 		$123K Hold
350
– – ﹤0.01% 1238
2022
Q2 		$154K Sell
350
-67
-16% -$37.1K ﹤0.01% 1146
2022
Q1 		$316K Hold
417
– – 0.01% 1061
2021
Q4 		$519K Buy
417
+25
+6% +$40.4K 0.01% 976
2021
Q3 		$792K Sell
392
-49
-11% -$105K 0.02% 896
2021
Q2 		$1.1M Buy
441
+30
+7% +$73.5K 0.02% 826
2021
Q1 		$1.02M Buy
411
+153
+59% +$455K 0.02% 854
2020
Q4 		$732K Hold
258
– – 0.02% 830
2020
Q3 		$609K Hold
258
– – 0.01% 823
2020
Q2 		$615K Buy
258
+27
+12% +$63.1K 0.01% 795
2020
Q1 		$465K Hold
231
– – 0.01% 794
2019
Q4 		$707K Buy
231
+94
+69% +$215K 0.01% 834
2019
Q3 		$334K Buy
137
+120
+706% +$328K ﹤0.01% 1075
2019
Q2 		$46K Hold
17
– – ﹤0.01% 1280
2019
Q1 		$43K Sell
17
-66
-80% -$187K ﹤0.01% 1317
2018
Q4 		$184K Sell
83
-17
-17% -$51.7K ﹤0.01% 1227
2018
Q3 		$446K Hold
100
– – ﹤0.01% 1172
2018
Q2 		$517K Hold
100
– – 0.01% 1118
2018
Q1 		$821K Buy
+100
New +$852K 0.01% 915

Other funds holding MBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bridgeway Capital Management's MBIO Position: Q1 2023 in Review

Bridgeway Capital Management sold out of Mustang Bio (MBIO) in Q1 2023, closing a stake of 284 shares — an estimated $84K sold.

Bridgeway Capital Management first reported a position in MBIO in Q1 2018 and held it in 20 quarters. The position peaked at $1.1M in Q2 2021. 48 funds tracked by Wall St. Rank hold MBIO as of Q1 2023.

  • Bridgeway Capital Management reported no remaining Mustang Bio position as of Q1 2023 after selling out during the quarter.
  • Bridgeway Capital Management sold 284 Mustang Bio shares in Q1 2023, an estimated $84K.
  • Bridgeway Capital Management first reported a position in Mustang Bio in Q1 2018 and held it in 20 quarters.
  • Bridgeway Capital Management's Mustang Bio position peaked at $1.1M in Q2 2021.
  • 48 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2023.

Based on Bridgeway Capital Management's 13F filing for Q1 2023, filed 15 May 2023.